Prävention des linksventrikulären Remodelings

作者: T. Thum , G. Ertl , J. Bauersachs

DOI: 10.1007/S12181-008-0072-2

关键词:

摘要: Die Umbauprozesse des Herzens nach einem Myokardinfarkt werden als „Remodeling“ bezeichnet, das charakterisiert ist durch Ausdunnung der infarzierten Myokardwand und strukturelle Umgestaltung uberlebenden Myokardanteile mit Myozytenhypertrophie, interstitieller Fibrose sowie Verformung Dilatation Herzkammer. Hemmer Renin-Angiotensin-Aldosteron-Systems vermindern Remodeling verbessern die Prognose bei Patienten eingeschrankter Ventrikelfunktion. Aldosteronantagonisten scheinen daruber hinaus auch fruhe Heilungsprozesse positiv zu beeinflussen. Zellbasierte Therapieansatze haben in ersten Studien positive Einflusse gezeigt, Nachweis anhaltender Effekte auf Herzfunktion, grosen randomisierten steht jedoch noch aus.

参考文章(67)
Thomas Thum, Johann Bauersachs, Philip A. Poole-Wilson, Hans-Dieter Volk, Stefan D. Anker, The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. Journal of the American College of Cardiology. ,vol. 46, pp. 1799- 1802 ,(2005) , 10.1016/J.JACC.2005.07.053
Johann Bauersachs, Marina Heck, Daniela Fraccarollo, Steven K Hildemann, Georg Ertl, Martin Wehling, Michael Christ, Addition of spironolactone to angiotensin-converting enzyme inhibition in heart failure improves endothelial vasomotor dysfunction: role of vascular superoxide anion formation and endothelial nitric oxide synthase expression. Journal of the American College of Cardiology. ,vol. 39, pp. 351- 358 ,(2002) , 10.1016/S0735-1097(01)01729-6
Gary F. Mitchell, Gervasio A. Lamas, Marc A. Pfeffer, Ventricular Remodeling after Myocardial Infarction Advances in Experimental Medicine and Biology. ,vol. 346, pp. 265- 276 ,(1993) , 10.1007/978-1-4615-2946-0_25
Michael J. Lipinski, Giuseppe G.L. Biondi-Zoccai, Antonio Abbate, Reena Khianey, Imad Sheiban, Jozef Bartunek, Marc Vanderheyden, Hyo-Soo Kim, Hyun-Jae Kang, Bodo E. Strauer, George W. Vetrovec, Impact of Intracoronary Cell Therapy on Left Ventricular Function in the Setting of Acute Myocardial Infarction Journal of the American College of Cardiology. ,vol. 50, pp. 1761- 1767 ,(2007) , 10.1016/J.JACC.2007.07.041
R Collins, R Peto, M Flather, S Parish, P Sleight, M Conway, A Pipilis, C Baigent, D Barnett, JP Boissel, A Budaj, J Cairns, L Ceremuzynski, AF Cohen, Gui De Backer, R Diaz, F Dienstl, P Dove, MG Franzosi, M Genoni, DA Halon, J Heikkila, C Hennekens, J Horgan, D Hunt, R Kala, N Karatzas, A Keech, M Keltai, J Kjekshus, M Kornitzer, R Koster, P Landless, P Lechleitner, A Leizorovicz, BS Lewis, L Lundkvist, S Macmahon, A Maggioni, R Malacrida, T Meyer, T Moccetti, D Ocallaghan, E Paolasso, LS Piegas, A Reikvam, P Ridker, T Ryan, R Schroder, R Seabragomes, JEMR Sousa, G Tognoni, A Turpie, V Valentin, J Varigos, H White, L Wilhelmsen, K Woods, S Yusuf, A Piombo, LA Guzman, DC Montenegro, G Irusta, RA Schneider, C Cuneo, BH Chamorro, GE Espinosa, M Moreno, MM Rios, R Doll, K Fox, D Julian, P Meier, E Sandoya, JE Perez, None, ISIS-4 - A randomised factorial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58.050 patient with suspected acute myocardial-infarction. The Lancet. ,vol. 345, pp. 669- 685 ,(1995)
Siyuan Le, Thomas J. Connors, Anna C. Maroney, c-Jun N-terminal kinase specifically phosphorylates p66ShcA at serine 36 in response to ultraviolet irradiation. Journal of Biological Chemistry. ,vol. 276, pp. 48332- 48336 ,(2001) , 10.1074/JBC.M106612200
Rekha Garg, Salim Yusuf, WD Bussmann, Peter Sleight, Andrew Uprichard, Barry Massie, Barry McGrath, Berit Nilsson, Bertram Pitt, Bruno Magnani, Carol Maskin, Ettore Ambrosioni, Ewa Rucinska, Franz X Kleber, Gary Jennings, Gianni Tognoni, Helmut Drexler, John GF Cleland, Joseph A Franciosa, Jouko Remes, Karl Swedberg, Kenneth Dickstein, Lothar Maass, Marc Pfeffer, Mark A Creager, Maryann Gordon, Michael Joy, Norman Sharpe, Pierre Desche, Robin McGarry, Rory Collins, Steven G Chrysant, Vincenzo Cicchetti, Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure JAMA: The Journal of the American Medical Association. ,vol. 273, pp. 1450- 1456 ,(1995) , 10.1001/JAMA.1995.03520420066040
Victor J Dzau, Kenneth Bernstein, David Celermajer, Jerome Cohen, Björn Dahlöf, John Deanfield, Javier Diez, Helmut Drexler, Roberto Ferrari, Wiek Van Gilst, Lennart Hansson, Burkhard Hornig, Ahsan Husain, Colin Johnston, Harold Lazar, Eva Lonn, Thomas Lüscher, John Mancini, Albert Mimran, Carl Pepine, Ton Rabelink, Willem Remme, Luis Ruilope, Marcel Ruzicka, Heribert Schunkert, Karl Swedberg, Thomas Unger, Douglas Vaughan, Michael Weber, None, Pathophysiologic and therapeutic importance of tissue ACE: a consensus report. Cardiovascular Drugs and Therapy. ,vol. 16, pp. 149- 160 ,(2002) , 10.1023/A:1015709617405
W Schorb, G W Booz, D E Dostal, K M Conrad, K C Chang, K M Baker, Angiotensin II is mitogenic in neonatal rat cardiac fibroblasts. Circulation Research. ,vol. 72, pp. 1245- 1254 ,(1993) , 10.1161/01.RES.72.6.1245